Site Editors

Alexander Drilon, MD

Gregory J. Riely, MD, PhD

Advertisement
Advertisement

Recent News

Pan-TRK Immunodetection of NTRK Fusions in Atypical Melanocytic Tumors
Gastrointestinal Malignancies: Biomarker Analysis Via Immunohistochemistry
Comparing Next-Generation Sequencing Assays: Which Is Best for NTRK Fusion Detection?
Morphologic and Molecular Characterization of NTRK Fusion Uterine Sarcoma
EML4-NTRK Gene Fusion and ALK Inhibitor Resistance: Case Study in Advanced Lung Cancer
Cervical Small Cell Neuroendocrine Cancer: PD-L1 Expression and NTRK Gene Fusion
Understanding NTRK Fusions and Their Role in Tumorigenesis
Defining Molecular Characteristics of First- and Second-Generation TRK Inhibitors
Study Update of Larotrectinib in Adults With TRK Fusion–Positive Cancer
How Does Larotrectinib Measure Up Against Entrectinib in Treatment of Tumors With NTRK Fusion?
Efficacy of Non-TRK Inhibitor Therapy in Patients With and Without NTRK Fusion–Positive Tumors
Larotrectinib for NTRK Fusion Tumors: Can a Patient’s Disease Course Before Therapy Affect Outcomes?
How Common Are NTRK1/2/3 Fusions in Colorectal Cancer?
How Familiar Are Health-Care Professionals With NTRK Fusion Testing in Patients With Solid Tumors?
ESMO 2021: Skeletal Fractures in Patients Treated With Larotrectinib for TRK Fusion–Positive Cancer
FDA Grants Breakthrough Therapy Designation to Repotrectinib for Solid Tumors With NTRK Gene Fusions
Case Study of NTRK1-Rearranged Cervical Sarcoma: Focus on Neoadjuvant TRK Inhibition and Surgery
Understanding NTRK Fusions in Premalignant Colorectal Lesions
ESMO 2021: Does Prior Therapy or Performance Status Affect Larotrectinib Response in TRK Fusion–Positive Cancer?
Molecular Characterization of Pediatric Versus Adult Papillary Thyroid Cancers
ESMO 2021: NTRK Fusion and KRAS Variation in Colorectal and Lung Cancers
ESMO 2021: Updated Analysis of Entrectinib in Advanced NTRK Fusion–Positive Solid Tumors
ESMO 2021: Dutch Study Focuses on NTRK Fusions as Potential Prognostic Biomarker
Rare Case of Recurrent Secretory Carcinoma of the Breast With NTRK3 Gene Fusion
Head and Neck Cancer in Chinese Patients: Focus on NTRK Aberrations
Novel Gene Fusion Partners in Sarcomas: Focus on NTRK for Targeted Therapy
NTRK Gene Fusion Analysis: Real-World Database of Patients With Cancer
Creative Treatment Approach to Advanced Salivary Gland Cancer With ETV6-NTRK3 Fusion: Case Study
Reassessing NTRK Testing in Patients With Bone Tumors
NTRK Gene Fusion Testing and Treatment Modifications: Survey of Medical Oncologists
Closer Look at NTRK Gene Fusions in Chinese Patients With Colorectal Cancer
Larotrectinib in TRK Fusion–Positive Cancers: Long-Term Follow-up
NTRK Gene Fusion in Middle Eastern Patients With Papillary Thyroid Cancer
Patterns of PD-L1 Expression in NSCLC Harboring Driver Oncogene Mutations Including NTRK Fusions
Positivity and Translocations of FGFR2 and NTRK1 in Intrahepatic Cholangiocarcinoma
UK Genomes Project: Are NTRK Gene Fusions Actionable Biomarkers?
Efficacy of Screening Methods for NTRK Gene Fusions in Solid Tumors
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.